Long-term humoral response following Delta and Omicron BA.1 co-infection

This study reports the 6-month humoral immune response in vaccinated patients concomitantly infected with Delta and Omicron BA.1 variants of SARS-CoV-2. Interestingly, the simultaneous exposure to the Delta and BA.1 S proteins does not confer an additional immune advantage compared to exposure to th...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	npj vaccines 2023-04, Vol.8 (1), p.57-57, Article 57
Hauptverfasser:	Saade, Carla, Pozzetto, Bruno, Yaugel-Novoa, Melyssa, Oriol, Guy, Josset, Laurence, Lina, Bruno, Paul, Stéphane, Bal, Antonin, Trouillet-Assant, Sophie
Format:	Artikel
Sprache:	eng
Schlagworte:	631/250/254 631/250/255/2514 Antibodies Biomedical and Life Sciences Biomedicine Brief Communication COVID-19 COVID-19 vaccines Immune response Immune system Immunity (Disease) Infectious Diseases Medical Microbiology Public Health Severe acute respiratory syndrome coronavirus 2 Vaccine Virology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	This study reports the 6-month humoral immune response in vaccinated patients concomitantly infected with Delta and Omicron BA.1 variants of SARS-CoV-2. Interestingly, the simultaneous exposure to the Delta and BA.1 S proteins does not confer an additional immune advantage compared to exposure to the BA.1 S protein alone.
ISSN:	2059-0105 2059-0105
DOI:	10.1038/s41541-023-00652-8